Open access
Journal
SINTA 1
Renal function and potassium changes in HFrEF patients treated with ACEI vs. ARNI: A prospective cohort study among Acehnese, Indonesia
Heart Science Journal · Vol. 7 No. 2 (2026) · pp. 70–75
ISSN 2721-9984, 2721-9976
Published 2026-04-26
Publisher Universitas Brawijaya
Language en
Abstract
Background: Renin-Angiotensin-Aldosterone System (RAAS) acceleration commonly occur in Heart Failure (HF). Drugs such as Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor-Neprilysin Inhibitors (ARNI) become essential part of HF treatment. Long-term consumption may impair kidney function and potassium imbalance, which could potentially limit the therapy, therefore we conducted this study to assess the effects of ACEI and ARNI on renal function and potassium level in Indonesian patients with heart failure with reduced ejection fraction (HFrEF), as no local studies exist. Method: A prospective cohort was performed in Banda Aceh, which comprise of 40 ACEI and 40 ARNI patients on standard therapy. Left ventricular ejection fraction (LVEF), serum creatinine level then converted into estimated Glomerular Filtration Rate (eGFR), and serum potassium level were measured at baseline and after 3 months into the therapy. Independent t-test was applied to compare groups. Result: Both ARNI and ACEI groups showed significant improvement in eGFR (p < 0.005). The intergroup difference was 11 mg/dL (p = 0.038) showed that ACEI had a better outcome in eGFR improvement compare with ARNI. Potassium rose slightly in both groups, with an intergroup difference of 0.082 mmol/L (p = 0.623), indicating no meaningful difference. Conclusion: Both ACEI and ARNI improved eGFR after 3 months, with a modest potassium increase.
Collaboration network of the authors
13 authors ·
30 co-authorship links
Hover or tap a name to highlight its co-authors. Double-click to open the author's page.
Universitas Syiah Kuala Affiliation unknown
Different organisations
Same organisation
Affiliation unknown
Thicker line = more joint articles · bigger circle = more articles
Show as table
Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.
Metadata source: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, first harvested 8 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title xml:lang="en">Renal function and potassium changes in HFrEF patients treated with ACEI vs. ARNI: A prospective cohort study among Acehnese, Indonesia</dc:title>
<dc:creator xml:lang="en">Munawarah, Iffah</dc:creator>
<dc:creator xml:lang="en">Heriansyah, Teuku</dc:creator>
<dc:creator xml:lang="en">Syukri, Maimun</dc:creator>
<dc:creator xml:lang="en">Purnawarman, Adi</dc:creator>
<dc:creator xml:lang="en">Buchari</dc:creator>
<dc:subject xml:lang="en">heart failure</dc:subject>
<dc:subject xml:lang="en"> ARNI</dc:subject>
<dc:subject xml:lang="en">ACEI</dc:subject>
<dc:subject xml:lang="en"> Creatinin</dc:subject>
<dc:subject xml:lang="en"> Pottasium</dc:subject>
<dc:description xml:lang="en">Background: Renin-Angiotensin-Aldosterone System (RAAS) acceleration commonly occur in Heart Failure (HF). Drugs such as Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor-Neprilysin Inhibitors (ARNI) become essential part of HF treatment. Long-term consumption may impair kidney function and potassium imbalance, which could potentially limit the therapy, therefore we conducted this study to assess the effects of ACEI and ARNI on renal function and potassium level in Indonesian patients with heart failure with reduced ejection fraction (HFrEF), as no local studies exist.
Method: A prospective cohort was performed in Banda Aceh, which comprise of 40 ACEI and 40 ARNI patients on standard therapy. Left ventricular ejection fraction (LVEF), serum creatinine level then converted into estimated Glomerular Filtration Rate (eGFR), and serum potassium level were measured at baseline and after 3 months into the therapy. Independent t-test was applied to compare groups.
Result: Both ARNI and ACEI groups showed significant improvement in eGFR (p &lt; 0.005). The intergroup difference was 11 mg/dL (p = 0.038) showed that ACEI had a better outcome in eGFR improvement compare with ARNI. Potassium rose slightly in both groups, with an intergroup difference of 0.082 mmol/L (p = 0.623), indicating no meaningful difference.
Conclusion: Both ACEI and ARNI improved eGFR after 3 months, with a modest potassium increase.</dc:description>
<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
<dc:date>2026-04-26</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20648</dc:identifier>
<dc:identifier>10.21776/ub.hsj.2026.007.02.10</dc:identifier>
<dc:source xml:lang="en">Heart Science Journal; Vol. 7 No. 2 (2026): The Evolving Landscape of Heart Failure; 70-75</dc:source>
<dc:source>2721-9984</dc:source>
<dc:source>2721-9976</dc:source>
<dc:source>10.21776/ub.hsj.2026.007.02</dc:source>
<dc:language>en</dc:language>
<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20648/581</dc:relation>
<dc:rights xml:lang="en">Copyright (c) 2026 Teuku Heriansyah, Iffah Munawarah, Maimun Syukri, Adi Purnawarman, Buchari</dc:rights>
<dc:rights xml:lang="en">http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>
Citations and indexing
OpenAlex
Indexed
via DOI
0 citations
Crossref
Indexed
via DOI
0 citations
Counts as reported by each index on 13 Nov 2026; indexes count citations differently.
OpenAlex also lists this work in: crossref.
Cite this article
APA 7
Munawarah, I., Heriansyah, T., Syukri, M., Purnawarman, A., & Buchari (2026). Renal function and potassium changes in HFrEF patients treated with ACEI vs. ARNI: A prospective cohort study among Acehnese, Indonesia. Heart Science Journal, 7(2), 70–75. https://doi.org/10.21776/ub.hsj.2026.007.02.10
Copy
IEEE
I. Munawarah, T. Heriansyah, M. Syukri, A. Purnawarman, and Buchari, “Renal function and potassium changes in HFrEF patients treated with ACEI vs. ARNI: A prospective cohort study among Acehnese, Indonesia,” Heart Science Journal, vol. 7, no. 2, pp. 70–75, 2026, doi: 10.21776/ub.hsj.2026.007.02.10.
Copy
Generated from the journal's metadata; check author names before use.